… -cell lung cancer after failure of erlotinib, gefitinib, or both, and one … afatinib (BIBW 2992)
in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib …

… that afatinib had greater efficacy than gefitinib or erlotinib in … However, afatinib was more
effective than erlotinib as second-… rate of afatinib was comparable to that of erlotinib but higher …

… of clinical use of three EGFR TKIs (afatinib, gefitinib, and erlotinib). We found that gefitinib
was more commonly used than erlotinib or afatinib in Korea, especially for elderly, which may …

… Thus, we undertook this phase 2b/3 study of afatinib in … 12 weeks of previous erlotinib or
gefitinib treatment, a group for … to be less sensitive to erlotinib and gefitinib. Patients did not need …

… studies comparing gefitinib, erlotinib, and afatinib. … While gefitinib, erlotinib, and afatinib have
proven efficacy in patients with … the efficacy of erlotinib, gefitinib, and afatinib in patients with …

… The current study indicated that erlotinib, gefitinib, afatinib and icotinib … Erlotinib and afatinib
revealed potentially better efficacy but significant higher toxicities compared with gefitinib …

… erlotinib/gefitinib. This phase III trial prospectively assessed whether continued irreversible
ErbB-family blockade with afatinib … resistance to erlotinib/gefitinib and afatinib monotherapy. …

… We surveyed the effectiveness of afatinib and gefitinib/erlotinib … However, Chiu et al.
reported gefitinib and erlotinib were … the efficacy of gefitinib/erlotinib and afatinib in patients with …

… Afatinib may overcome tumor heterogeneity, leading to T790M colonal purity. We aimed to
determine whether NSCLC treatment with afatinib followed by osimertinib (afatinib … afatinib …

… afatinib, erlotinib, gefitinib and encorafenib and the O⿿desmethyl metabolites of erlotinib
and gefitinib … isotopically labeled internal standard of afatinib, erlotinib, gefitinib and OSI-420. …